Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study

Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of the American Academy of Dermatology Unpaywall

Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study

Loading next page...
 
/lp/unpaywall/secukinumab-for-moderate-to-severe-palmoplantar-pustular-psoriasis-o1RhgXhQlL

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
0190-9622
DOI
10.1016/j.jaad.2019.01.066
Publisher site
See Article on Publisher Site

Abstract

Journal

Journal of the American Academy of DermatologyUnpaywall

Published: May 1, 2019

There are no references for this article.